PINK1/Parkin‐mediated mitophagy promotes apelin‐13‐induced vascular smooth muscle cell proliferation by AMPKα and exacerbates atherosclerotic lesions
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Aberrant proliferation of vascular smooth muscle cells (VSMC) is a critical contributor to the pathogenesis of atherosclerosis (AS). Our previous studies have demonstrated that apelin‐13/APJ confers a proliferative response in VSMC, however, its underlying mechanism remains elusive. In this study, we aimed to investigate the role of mitophagy in apelin‐13‐induced VSMC proliferation and atherosclerotic lesions in apolipoprotein E knockout (ApoE‐/‐) mice. Apelin‐13 enhances human aortic VSMC proliferation and proliferative regulator proliferating cell nuclear antigen expression in dose and time‐dependent manner, while is abolished by APJ antagonist F13A. We observe the engulfment of damage mitochondria by autophagosomes (mitophagy) of human aortic VSMC in apelin‐13 stimulation. Mechanistically, apelin‐13 increases p‐AMPKα and promotes mitophagic activity such as the LC3I to LC3II ratio, the increase of Beclin‐1 level and the decrease of p62 level. Importantly, the expressions of PINK1, Parkin, VDAC1, and Tom20 are induced by apelin‐13. Conversely, blockade of APJ by F13A abolishes these stimulatory effects. Human aortic VSMC transfected with AMPKα, PINK1, or Parkin and subjected to apelin‐13 impairs mitophagy and prevents proliferation. Additional, apelin‐13 not only increases the expression of Drp1 but also reduces the expressions of Mfn1, Mfn2, and OPA1. Remarkably, the mitochondrial division inhibitor‐1(Mdivi‐1), the pharmacological inhibition of Drp1, attenuates human aortic VSMC proliferation. Treatment of ApoE‐/‐ mice with apelin‐13 accelerates atherosclerotic lesions, increases p‐AMPKα and mitophagy in aortic wall in vivo. Finally, PINK1‐/‐ mutant mice with apelin‐13 attenuates atherosclerotic lesions along with defective in mitophagy. PINK1/Parkin‐mediated mitophagy promotes apelin‐13‐evoked human aortic VSMC proliferation by activating p‐AMPKα and exacerbates the progression of atherosclerotic lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Vascular smooth muscle cells in atherosclerosis
Bennett, M. R., Sinha, S., & Owens, G. K. (2016) · Circulation Research · doi:10.1161/circresaha.115.306361 · Cited by 2,179 · cited 2×
“FBS: fetal bovine serum; VMSC: vascular smooth muscle cell AS is a chronic inflammatory disease which is characterized by the accumulation of lipid‐containing plaques in the vascular wall (Bennett et al., 2016).”
BackgroundPINK1-dependent recruitment of Parkin to mitochondria in mitophagy
Vives-Bauza, C., Zhou, C., Huang, Y., Cui, M., de Vries, R. L. A., Kim, J., May, J., Tocilescu, M. A., Liu, W., Ko, H. S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911187107 · Cited by 1,616 · cited 2×
“The PINK1‐Parkin in a common pathway appears to the regulation of mitophagy (Eiyama & Okamoto, 2015; Vives‐Bauza et al., 2010).”
BackgroundAMP-activated protein kinase mediates mitochondrial fission in response to energy stress
Toyama, E. Q., Herzig, S., Courchet, J., Lewis, T. L., Losón, O. C., Hellberg, K., Young, N. P., Chen, H., Polleux, F., Chan, D. C., et al. (2016) · Science · doi:10.1126/science.aab4138 · Cited by 1,085 · cited 2×
“In particular, AMPKα plays an essential for efficient mitophagy to prevent the progression of heart failure (Toyama et al., 2016).”
BackgroundRecent insights into the cellular biology of atherosclerosis
Tabas, I., García-Cardeña, G., & Owens, G. K. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201412052 · Cited by 1,016
Autophagy and mitophagy in cardiovascular disease
Bravo-San Pedro, J. M., Kroemer, G., & Galluzzi, L. (2017) · Circulation Research · doi:10.1161/circresaha.117.311082 · Cited by 843
PINK1/Parkin-mediated mitophagy in mammalian cells
Eiyama, A., & Okamoto, K. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.01.002 · Cited by 603 · cited 2×
“Subsequently, PINK1/Parkin promotes autophagosome formation via LC3‐interacting region domain to initiate mitophagy, revealing that PINK1 and Parkin are key factors for mediating mitophagy (Eiyama & Okamoto, 2015; Vives‐Bauza et al., 2010).”
BackgroundWang, B., Nie, J., Wu, L., Hu, Y., Wen, Z., Dong, L., Zou, M.-H., Chen, C., & Wang, D. W. (2018) · Circulation Research · doi:10.1161/circresaha.117.312317 · Cited by 334 · cited 2×
“The importance of VSMC functions in the progression of AS, especially VSMC proliferation has been extensively reported (Uhrin et al., 2018; D. Wang et al., 2018).”
BackgroundHu, C., Huang, Y., & Li, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010144 · Cited by 302
Self-citationDefective autophagy in atherosclerosis: to die or to senesce?
Grootaert, M. O. J., Roth, L., Schrijvers, D. M., De Meyer, G. R. Y., & Martinet, W. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7687083 · Cited by 147 · cited 2×
“More important, mitophagy via PINK1/Parkin pathway plays a protective role of stabilize atherosclerotic plaque (Grootaert et al., 2018).”
Background
Cited by
Mitophagy in cardiovascular diseases: molecular mechanisms, pathogenesis, and treatment
Ajoolabady, A., Chiong, M., Lavandero, S., Klionsky, D. J., & Ren, J. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.06.007 · Cited by 258
Targeting the apelin system for the treatment of cardiovascular diseases
Chapman, F. A., Maguire, J. J., Newby, D. E., Davenport, A. P., & Dhaun, N. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad171 · Cited by 104
“It promotes vascular smooth muscle cell proliferation, 73 and loss of the apelin receptor protects against the development of atherosclerosis in the apolipoprotein E knockout mouse.”
BackgroundNing, R., Li, Y., Du, Z., Li, T., Sun, Q., Lin, L., Xu, Q., Duan, J., & Sun, Z. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102113 · Cited by 96
“Mitochondrial defects and atherosclerotic lesions were reduced in PINK1 /− mice after apelin-13 treatment [60].”
Giovarelli, M., Zecchini, S., Martini, E., Garrè, M., Barozzi, S., Ripolone, M., Napoli, L., Coazzoli, M., Vantaggiato, C., Roux-Biejat, P., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-020-0510-7 · Cited by 41
“[54], several lines of evidence support this activity [41, 55, 56] showing that Mdivi-1 reduces Drp1 levels, prevents mitochondrial fragmentation, enhances fusion and promotes the formation of mitochondrial network and we confirm these findings.”
Apelin/APJ system: A novel therapeutic target for locomotor system diseases
Luo, J., Liu, W., Feng, F., & Chen, L. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174286 · Cited by 28
Self-citationAutophagy: a killer or guardian of vascular smooth muscle cells
Zhang, Y.-Y., Shi, Y.-N., Zhu, N., Wang, W., Deng, C.-F., Xie, X.-J., Liao, D.-F., & Qin, L. (2020) · Journal of Drug Targeting · doi:10.1080/1061186x.2019.1705312 · Cited by 24
“Therefore, inhibition of mitophagy might be a promising strategy for the treatment of atherosclerosis [61].”
BackgroundA Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease
Chen, H., Chen, F., Jiang, Y., Zhang, L., Hu, G., Sun, F., Zhang, M., Ji, Y., Chen, Y., Che, G., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.881239 · Cited by 19
Apelin is expressed in intimal smooth muscle cells and promotes their phenotypic transition
Cardoso Dos Santos, L. M., Azar, P., Brun, C., König, S., Roatti, A., Baertschi, A. J., Chaabane, C., & Bochaton-Piallat, M.-L. (2023) · Scientific Reports · doi:10.1038/s41598-023-45470-z · Cited by 9
Metadata
- Authors
- He, L., Zhou, Q., Huang, Z., Xu, J., Zhou, H., Lv, D., Lu, L., Huang, S., Tang, M., Zhong, J., Chen, J., Luo, X., Li, L., & Chen, L.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2018-11-19
- Volume
- 234
- Issue
- 6
- Pages
- 8668-8682
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2900900438
- Cited by
- 134
- References
- 10
- FWCI
- 6.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.